Our specialists treat a variety of digestive diseases with the goal of helping patients feel normal again.
UT Southwestern’s nationally recognized general gastroenterology specialists focus on the prevention, diagnosis, and treatment of digestive system disorders. We are dedicated to providing superior care to patients who have conditions affecting the gastrointestinal (GI) tract.
We also collaborate with specialists in other areas to provide the best care for specific conditions, such as liver diseases, inflammatory bowel disease, motility disorders, and pancreatobiliary disorders.
Our multidisciplinary team includes gastroenterologists, physician assistants, nurses, nurse practitioners, medical assistants, clinic assistants, and GI fellows who work together to deliver the best experience possible for our patients.
Nationally Recognized Care for the Best Patient OutcomesOur team has extensive experience in the diagnosis and treatment of all conditions that affect the GI tract. Among the conditions we routinely help manage are:
- Acid reflux
- Celiac disease
- Colon cancer
- Duodenal ulcers
- GI bleeding
- H. pylori infections
- Iron-deficiency anemia
- Irritable bowel syndrome
- Microscopic colitis
- Stomach ulcers
Diagnosing General Gastroenterology Conditions
Our gastroenterologists evaluate patients who have experienced symptoms such as abdominal pain, acid reflux/heartburn, or other problems with digestion.
If our team suspects a gastroenterological condition, we first conduct a thorough physical examination and talk with the patient about his or her medical and family history.
To provide the most comprehensive and timely care, we also use the latest diagnostic technologies, such as:
- Esophageal manometry
- Nasal and BRAVO pH testing
- Office-based hydrogen breath tests
- Single and double balloon enteroscopy
- SMART pill
- Upper endoscopy (EGD)
- Video capsule endoscopy (PillCam)
Treating General Gastroenterology ConditionsTreatment varies depending on the condition, its severity, and the unique needs of the patient. Medications are typically the first line of treatment. Surgery is sometimes used in severe cases that do not respond to medication.
Our patients have access to promising new treatments through phase II and III clinical trials. For patients with inflammatory bowel disease, we have a specially trained IBD research coordinator to assist them throughout their participation.
Showing 3 locations